Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2016
vol. 118 abstract:
Review paper
Experimental studies on cell and gene therapies for retinal dystrophies with a particular focus on ABCA4 retinopathies
Aneta Ścieżyńska
1
,
Dominika Oziębło
2
,
Monika Ołdak
1, 2, 3
1.
Katedra i Zakład Histologii i Embriologii, Centrum Biostruktury, Warszawski Uniwersytet Medyczny
2.
Zakład Genetyki, Instytut Fizjologii i Patologii Słuchu w Warszawie
3.
Samodzielny Publiczny Kliniczny Szpital Okulistyczny w Warszawie
Online publish date: 2017/11/29
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Retinal dystrophies lead to gradual irreversible vision deterioration. The ABCA4 retinopathies constitute an important group of retinal dystrophies. However, there are no effective therapies available for this group of diseases. Yet, with the advent of molecular therapies, the development of prospective therapeutic approaches seems feasible. The paper summarizes recent advances in gene and cell therapy that may be implemented in retinal dystrophies, especially in ABCA4-associated diseases.
keywords:
ABCA4 gene, Stargardt disease, retinal dystrophies, gene therapy, cell therapy, clinical trials |
|